Valeo Pharma Inc.(VPHIF)

$0.00—Stale · unknown oldEarnings in 2d

Valeo Pharma Inc.(VPHIF)

OTCMARKET • Last print unknown ago

$0.00—Stale · unknown oldEarnings in 2d

VPHIF(VPHIF)

VPHIF

Next report

Dec 30 2026in 95 days

EPS estimate

($0.02)

Revenue estimate

$3M

EPS beats

1 of last 11

Each report against the estimate that stood when it landed.

Sep 22 2021Sep 12 2024

Reported	EPS est	EPS actual	Surprise	Revenue est	Revenue actual	Surprise
Sep 12 2024	($0.04)	($0.06)	-65.2%	$10M	$9M	-6.7%
Jun 13 2024	($0.04)	($0.06)	-60.0%	$11M	$10M	-8.8%
Mar 15 2024	($0.06)	($0.06)	-6.7%	$11M	$10M	-6.0%
Sep 14 2023	($0.04)	($0.05)	-23.5%	$12M	$11M	-14.1%
Jun 14 2023	($0.05)	($0.06)	-14.3%	$10M	$10M	-2.6%
Mar 16 2023	($0.05)	($0.13)	-160.0%	$10M	$10M	+0.7%
Jan 31 2023	($0.04)	($0.09)	-139.9%	$7M	$9M	+35.1%
Sep 13 2022	($0.05)	($0.06)	-20.0%	$5M	$5M	+1.7%
Jun 14 2022	($0.06)	($0.06)	+0.0%	$5M	$4M	-26.0%
Mar 24 2022	($0.04)	($0.07)	-75.0%	$4M	$3M	-18.1%
Sep 22 2021	($0.03)	($0.04)	-33.3%	$3M	$5M	+48.1%
Jun 29 2021	—	($0.02)	—	—	$2M	—

Forward Growth Estimates (YoY)

FY2027

Rev+3.86%

EPS+18.75%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Quarterly

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$4M	$4M	$3M	$4M	$5M	$5M	$9M	$10M
Low	$4M	$4M	$3M	$4M	$5M	$5M	$9M	$10M
High	$4M	$4M	$3M	$4M	$5M	$5M	$9M	$10M
EBITDA Avg	$1M	$1M	$-3M	$730,694	$-2M	$-1M	$-465,015	$-4M
Low	$1M	$1M	$-3M	$730,694	$-2M	$-1M	$-465,015	$-4M
High	$1M	$1M	$-3M	$730,694	$-2M	$-1M	$-465,015	$-4M
EBIT Avg	$517,323	$517,323	$-4M	$32,729	$-3M	$-2M	$-1M	$-4M
Low	$517,323	$517,323	$-4M	$32,729	$-3M	$-2M	$-1M	$-4M
High	$517,323	$517,323	$-4M	$32,729	$-3M	$-2M	$-1M	$-4M
Net Income Avg	$-3M	$-3M	$-8M	$-4M	$-6M	$-6M	$-5M	$-8M
Low	$-3M	$-3M	$-8M	$-4M	$-6M	$-6M	$-5M	$-8M
High	$-3M	$-3M	$-8M	$-4M	$-6M	$-6M	$-5M	$-8M
EPS Avg	$-0.03	$-0.03	$-0.08	$-0.04	$-0.07	$-0.06	$-0.05	$-0.08
Low	$-0.03	$-0.03	$-0.08	$-0.04	$-0.07	$-0.06	$-0.05	$-0.08
High	$-0.03	$-0.03	$-0.08	$-0.04	$-0.07	$-0.06	$-0.05	$-0.08
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

No earnings transcripts available for VPHIF

Transcripts may not be available for all companies

Explore More

Stocks breaking to new annual highs

S&P 500 oversold value screener

Relative strength momentum leaders

Upcoming earnings dates & reports

Filter and sort all 500 stocks

Continuous multi-factor scoring & catalyst forensics

Today's biggest gainers and losers